找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Radiation Oncology Study Guide; Ravi A. Chandra,Celine B. Ord,Charles R. Thomas Jr Textbook 2021Latest edition Springer Nature Switzerland

[復制鏈接]
樓主: 不讓做的事
21#
發(fā)表于 2025-3-25 03:25:17 | 只看該作者
Skin Cancer and Uveal Melanoma,in clinical staging per the American Joint Committee on Cancer and novel therapeutic agents. Given the rarity of uveal melanoma, this disease entity is briefly included in the same chapter as cutaneous melanoma as radiation is an integral component of management organ preservation.
22#
發(fā)表于 2025-3-25 11:12:48 | 只看該作者
Head and Neck Cancer,clude updates in clinical staging as introduced by the American Joint Committee on Cancer, management of HPV-positive oropharynx cancer, approaches to cervical node management, and new information on systemic regimens in the setting of concurrent or sequential chemoradiation.
23#
發(fā)表于 2025-3-25 12:38:35 | 只看該作者
Thoracic Cancer,herapy, and advancements in concurrent chemoradiation. This section has also been expanded to incorporate major studies in NSCLC highlighting dose escalation and the use of adjuvant immunotherapy. Also, this section includes role of consolidative radiation and prophylactic cranial radiation in SCLC.
24#
發(fā)表于 2025-3-25 19:43:43 | 只看該作者
25#
發(fā)表于 2025-3-25 21:25:17 | 只看該作者
26#
發(fā)表于 2025-3-26 00:31:20 | 只看該作者
27#
發(fā)表于 2025-3-26 08:06:18 | 只看該作者
28#
發(fā)表于 2025-3-26 08:55:03 | 只看該作者
Breast Cancer, mitigate toxicity. Additionally, molecular testing has opened up avenues for successful targeted agents and reassessment in radiation therapy strategies. This section has been expanded to incorporate the aforementioned evolution of breast radiotherapy.
29#
發(fā)表于 2025-3-26 13:13:03 | 只看該作者
30#
發(fā)表于 2025-3-26 19:10:38 | 只看該作者
Pediatric Non-CNS Tumors,kemia, lymphoma, neuroblastoma, Wilms’ tumor, Ewing sarcoma, rhabdomyosarcoma, and retinoblastoma. Similar to pediatric CNS tumors, treatment strategies for pediatric body tumors continue to evolve as we learn more about molecular markers and targeted novel therapies.
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2026-1-25 11:44
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
锡林郭勒盟| 项城市| 新民市| 沛县| 滨海县| 宁海县| 柏乡县| 三河市| 宁国市| 东城区| 兴和县| 渭源县| 遵义市| 盘山县| 泸定县| 潍坊市| 兴城市| 黄冈市| 大石桥市| 沙湾县| 临颍县| 镇赉县| 阿合奇县| 柘城县| 元朗区| 五莲县| 嵊州市| 苍梧县| 河西区| 林甸县| 达日县| 民县| 商洛市| 大安市| 峡江县| 延边| 东乡县| 广汉市| 临夏县| 于田县| 承德县|